HMGB1 and Miyoshi myopathy: Furthermore, TAK-242 treatment significantly reduced scratch closure rates and decreased the number of invasive cells in Transwell assays (Figure S4), further supporting the interplay between TLR4 and HMGB1 in regulating MM cell behavior.